| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 03/29/2007 | WO2007034958A1 Anti-angiogenic composition comprising grain-derived component as active ingredient |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007034327A1 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 03/29/2007 | WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 03/29/2007 | WO2006119258A3 Use of hydrogen sulfide in the treatment of eye diseases |
| 03/29/2007 | WO2006108128A3 Ocular delivery of interferon-tau |
| 03/29/2007 | WO2006102378A3 Drug delivery systems for treatment of diseases or conditions |
| 03/29/2007 | WO2006099325A3 Methods of treating ear infections |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | DE60119337T2 Aseptische mittel Aseptic medium |
| 03/29/2007 | CA2622870A1 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1765785A1 Prostaglandin analogs |
| 03/28/2007 | EP1765381A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/28/2007 | EP1765315A2 Abnormal cannabidiols for lowering intraocular pressure |
| 03/28/2007 | EP1696958B1 Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 03/28/2007 | EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities |
| 03/28/2007 | CN1938011A Pharmaceutical product containing tranilast |
| 03/28/2007 | CN1935838A Thymosin beta4 derivative and itsuse |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935174A Animal medicament with expelling toxin bycooling, calming liver to brighten vision and its preparing method |
| 03/28/2007 | CN1935173A Animal medicament with expelling toxin bycooling, purging liver to brighten vision and its preparing method |
| 03/28/2007 | CN1935165A Moringaceae tablet and its producing method |
| 03/28/2007 | CN1935161A Ear antibacterial agent |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1307300C Hematopoietic stem cells and methods of treatment neogenesis vascular ophthalmopathy |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1306940C Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/28/2007 | CN1306938C Combination for local use for preventing and treating ocular disease |
| 03/28/2007 | CN1306936C Eye drop of tobramycin and sodium hyaluronate and its prepn process |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196098 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196082 Ophthalmic compositions for treating ocular hypertension |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | CA2370244C Piperidine derivatives |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007000641A3 Prostaglandin derivatives |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065442 Compositions and methods for treating hyperimmune response in the eye |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1515710B1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | CN1934109A Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933840A Use of a phenothiazine derivative for preventing and/or treating hearing loss |
| 03/21/2007 | CN1931349A Antiviral eye drop containing zedoary oil |
| 03/21/2007 | CN1931299A Chinese herbal medicine enama for treating immunological eye diseases and its prepn process |
| 03/21/2007 | CN1931191A Medicine composition for treating senile cataract in initial stage and its prepn process |
| 03/21/2007 | CN1931170A Gatifloxacin ear drop and its prepn process |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/21/2007 | CN1305509C Medicine composition for treating labyrinthine syndrome and its preparation method |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192969 Ester derivatives |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192959 Sodium channel blockers |
| 03/20/2007 | US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192595 Peptide-based vaccine for influenza |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/15/2007 | WO2007030307A2 Method of treating glaucoma |
| 03/15/2007 | WO2007028821A2 Treatment of autoimmune diseases |
| 03/15/2007 | WO2006105403A3 Treatment of eye disorders with sirtuin modulators |
| 03/15/2007 | WO2006104760A3 OPHTHALMIC COMPOSITIONS COMPRISING dDC |
| 03/15/2007 | WO2006091801A3 Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors |
| 03/15/2007 | US20070060647 Gene expression regulating agent |
| 03/15/2007 | US20070060628 Use of 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl] thiazolidine-2,4-dione |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer |
| 03/15/2007 | CA2620554A1 Treatment of autoimmune diseases |
| 03/15/2007 | CA2620156A1 Method of treating glaucoma |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |